A randomized double-blind placebo-controlled phase II study of the matrix metalloprotease inhibitor prinomastat in combination with temozolomide following radiation therapy in patients having newly diagnosed glioblastoma multiforme
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2009
At a glance
- Drugs Prinomastat; Temozolomide
- Indications Glioblastoma
- Focus Therapeutic Use
- 22 Sep 2009 Last checked against ClinicalTrials.gov record.
- 22 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 11 Sep 2005 New trial record.